| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c3f9300f8484da0ea0f47374781b77f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81946deb058c0de9877baab02952cec4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate |
2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0845360c08eac06f3c1134b2e7d53929 |
| publicationDate |
2006-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006110642-A2 |
| titleOfInvention |
Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence |
| abstract |
Compositions for reducing dependency and addiction to substances of abuse are provided. Chloride channels such as the GABAA receptors are altered under conditions of dependency and withdrawal such that the electrophysiological properties of the GABAA receptor containing neurons are altered thereby providing a pathophysiological condition resulting in symptoms of dependency and withdrawal such as anxiety. Specifically, under conditions of withdrawal the relative ratio of the a1 receptor subunit decreases relative to the a4 receptor subunit. Endogenous neurosteroid production is also associated with the molecular changes underlying the alterations of GABA-gated chloride channels. Compositions of at least two compounds including at least one inhibitor of neurosteroid production are useful for treating the pathophysiology of addiction, dependency and substance abuse withdrawal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920833-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9481681-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8691270-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685447-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7863267-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8927014-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8927013-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920834-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745406-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486449-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9206190-B2 |
| priorityDate |
2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |